UBS lowered the firm’s price target on Progressive (PGR) to $226 from $234 and keeps a Buy rating on the shares. Insurance brokers are well positioned for 2026, with organic revenue growth averaging 4.4% and EBITDA margins improving year over year despite property rate pressures, the analyst tells investors in a research note. With growth expectations reset and valuations reflecting a softer market, there is upside to consensus EPS and potential for multiple expansion, the firm says.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PGR:
- Progressive price target lowered to $225 from $252 at Keefe Bruyette
- Progressive price target lowered to $232 from $239 at BMO Capital
- Progressive: Sustained Policy Momentum, Elevated Profitability, and Valuation Upside Support Buy Rating
- Progressive reports strong Q4 2025 results, announces CFO transition
- Morning Movers: Starbucks rises after Q1 results and FY26 guidance